1534 related articles for article (PubMed ID: 25816561)
1. [Early achievements of the Danish pharmaceutical industry-7].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2014; (42):31-62. PubMed ID: 25816561
[TBL] [Abstract][Full Text] [Related]
2. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
3. [Early achievements of the Danish pharmaceutical industry-6 Pharmacia].
Grevsen JV; Kruse E; Kruse PR
Theriaca; 2014; (42):9-30. PubMed ID: 25816560
[TBL] [Abstract][Full Text] [Related]
4. [Early achievements of the Danish pharmaceutical industry--2. The minor and almost forgotten pharmaceutical companies].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2009; (38):7-71. PubMed ID: 20027788
[TBL] [Abstract][Full Text] [Related]
5. [Early achievements of the Danish pharmaceutical industry--3. Alfred Benzon].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2011; (39):7-51. PubMed ID: 21879529
[TBL] [Abstract][Full Text] [Related]
6. [The story of K.V. Tjellesen].
Clemmensen P
Theriaca; 2005; (36):7-26. PubMed ID: 17144610
[TBL] [Abstract][Full Text] [Related]
7. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
8. Innovation strategies for generic drug companies: moving into supergenerics.
Ross MS
IDrugs; 2010 Apr; 13(4):243-7. PubMed ID: 20373253
[TBL] [Abstract][Full Text] [Related]
9. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
10. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
11. [Early achievements of the Danish pharmaceutical industry--1 Novo Nordisk].
Kruse E
Theriaca; 2008; (37):9-26. PubMed ID: 18548941
[TBL] [Abstract][Full Text] [Related]
12. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
13. [From "Løveapotekets kemiske Fabrik" to LEO Pharma A/S].
Schrøder P
Theriaca; 2005; (36):27-118. PubMed ID: 17144611
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Generics market in Greece: the pharmaceutical industry's beliefs.
Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
17. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
[TBL] [Abstract][Full Text] [Related]
18. What's in a name? Generics and the persistence of the pharmaceutical brand in American medicine.
Greene JA
J Hist Med Allied Sci; 2011 Oct; 66(4):468-506. PubMed ID: 20858701
[TBL] [Abstract][Full Text] [Related]
19. [The factory Ferraton from idea to realization].
Hey AW
Theriaca; 2014; (42):63-7. PubMed ID: 25816562
[No Abstract] [Full Text] [Related]
20. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
